Literature DB >> 21276449

The Evi1, microRNA-143, K-Ras axis in colon cancer.

Jin-Song Gao1, Yingjie Zhang, Xiaoli Tang, Lynne D Tucker, Patrick M Tarwater, Peter J Quesenberry, Isidore Rigoutsos, Bharat Ramratnam.   

Abstract

MicroRNA profiling of diseased/non-diseased tissue has identified expression signatures associated with a wide range of pathogenic conditions including malignancy. For example, colon cancer is associated with the under expression of miRNA-143 yet the molecular etiology of under expression is unknown. The K-Ras oncogene is a target of miRNA-143. Here, we show that the ecotropic viral integration site 1 oncoprotein (Evi1) is a transcriptional suppressor of the miRNA-143 gene. We find an indirect relationship between miRNA-143 and Evi1 expression. A complex molecular axis linking Evi1, miRNA-143 is operational in human colon cancer.
Copyright © 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21276449      PMCID: PMC3440864          DOI: 10.1016/j.febslet.2011.01.033

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  20 in total

1.  Role of miR-143 targeting KRAS in colorectal tumorigenesis.

Authors:  X Chen; X Guo; H Zhang; Y Xiang; J Chen; Y Yin; X Cai; K Wang; G Wang; Y Ba; L Zhu; J Wang; R Yang; Y Zhang; Z Ren; K Zen; J Zhang; C-Y Zhang
Journal:  Oncogene       Date:  2009-01-12       Impact factor: 9.867

2.  Extensive post-transcriptional regulation of microRNAs and its implications for cancer.

Authors:  J Michael Thomson; Martin Newman; Joel S Parker; Elizabeth M Morin-Kensicki; Tricia Wright; Scott M Hammond
Journal:  Genes Dev       Date:  2006-08-01       Impact factor: 11.361

3.  MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers.

Authors:  Yukihiro Akao; Yoshihito Nakagawa; Tomoki Naoe
Journal:  Oncol Rep       Date:  2006-10       Impact factor: 3.906

4.  Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer.

Authors:  Meera Nanjundan; Yasuhisa Nakayama; Kwai Wa Cheng; John Lahad; Jinsong Liu; Karen Lu; Wen-Lin Kuo; Karen Smith-McCune; David Fishman; Joe W Gray; Gordon B Mills
Journal:  Cancer Res       Date:  2007-04-01       Impact factor: 12.701

5.  MicroRNA signatures in human ovarian cancer.

Authors:  Marilena V Iorio; Rosa Visone; Gianpiero Di Leva; Valentina Donati; Fabio Petrocca; Patrizia Casalini; Cristian Taccioli; Stefano Volinia; Chang-Gong Liu; Hansjuerg Alder; George A Calin; Sylvie Ménard; Carlo M Croce
Journal:  Cancer Res       Date:  2007-09-15       Impact factor: 12.701

6.  MicroRNA-125b is a novel negative regulator of p53.

Authors:  Minh T N Le; Cathleen Teh; Ng Shyh-Chang; Huangming Xie; Beiyan Zhou; Vladimir Korzh; Harvey F Lodish; Bing Lim
Journal:  Genes Dev       Date:  2009-03-17       Impact factor: 11.361

7.  Genomic analysis of human microRNA transcripts.

Authors:  Harpreet Kaur Saini; Sam Griffiths-Jones; Anton James Enright
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-26       Impact factor: 11.205

8.  Decreased expression of microRNA-143 and -145 in human gastric cancers.

Authors:  Takeshi Takagi; Akio Iio; Yoshihito Nakagawa; Tomoki Naoe; Nobuhiko Tanigawa; Yukihiro Akao
Journal:  Oncology       Date:  2009-05-12       Impact factor: 2.935

9.  MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy.

Authors:  Joanne B Weidhaas; Imran Babar; Sunitha M Nallur; Phong Trang; Sarah Roush; Michelle Boehm; Erin Gillespie; Frank J Slack
Journal:  Cancer Res       Date:  2007-12-01       Impact factor: 12.701

Review 10.  The oncogene and developmental regulator EVI1: expression, biochemical properties, and biological functions.

Authors:  Rotraud Wieser
Journal:  Gene       Date:  2007-04-20       Impact factor: 3.688

View more
  14 in total

1.  EVI and MDS/EVI are required for adult intestinal stem cell formation during postembryonic vertebrate development.

Authors:  Morihiro Okada; Yun-Bo Shi
Journal:  FASEB J       Date:  2017-09-19       Impact factor: 5.191

Review 2.  MicroRNAs targeting EGFR signalling pathway in colorectal cancer.

Authors:  Jitka Mlcochova; Petra Faltejskova; Radim Nemecek; Marek Svoboda; Ondrej Slaby
Journal:  J Cancer Res Clin Oncol       Date:  2013-07-02       Impact factor: 4.553

3.  Ecotropic viral integration site 1 regulates the progression of acute myeloid leukemia via MS4A3-mediated TGFβ/EMT signaling pathway.

Authors:  Min Jiang; Xueqin Zou; Wenhua Huang
Journal:  Oncol Lett       Date:  2018-06-04       Impact factor: 2.967

4.  EVI1 splice variants modulate functional responses in ovarian cancer cells.

Authors:  Punashi Dutta; Tuyen Bui; Kyle A Bauckman; Khandan Keyomarsi; Gordon B Mills; Meera Nanjundan
Journal:  Mol Oncol       Date:  2013-03-05       Impact factor: 6.603

5.  miR-143 decreases COX-2 mRNA stability and expression in pancreatic cancer cells.

Authors:  Hung Pham; C Ekaterina Rodriguez; Graham W Donald; Kathleen M Hertzer; Xiaoman S Jung; Hui-Hua Chang; Aune Moro; Howard A Reber; O Joe Hines; Guido Eibl
Journal:  Biochem Biophys Res Commun       Date:  2013-08-21       Impact factor: 3.575

6.  Implications of microRNAs in colorectal cancer development, diagnosis, prognosis, and therapeutics.

Authors:  Haiyan Zhai; Jingfang Ju
Journal:  Front Genet       Date:  2011-11-03       Impact factor: 4.599

Review 7.  Evi1 forms a bridge between the epigenetic machinery and signaling pathways.

Authors:  Akihide Yoshimi; Mineo Kurokawa
Journal:  Oncotarget       Date:  2011-07

8.  Tissue-specific upregulation of MDS/EVI gene transcripts in the intestine by thyroid hormone during Xenopus metamorphosis.

Authors:  Thomas C Miller; Guihong Sun; Takashi Hasebe; Liezhen Fu; Rachel A Heimeier; Biswajit Das; Atsuko Ishizuya-Oka; Yun-Bo Shi
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

9.  Restoration of miR-1228* expression suppresses epithelial-mesenchymal transition in gastric cancer.

Authors:  Litao Jia; Jia Wu; Lu Zhang; Jiamin Chen; Dandan Zhong; Song Xu; Chuangao Xie; Jianting Cai
Journal:  PLoS One       Date:  2013-03-12       Impact factor: 3.240

10.  Argonaute CLIP-Seq reveals miRNA targetome diversity across tissue types.

Authors:  Peter M Clark; Phillipe Loher; Kevin Quann; Jonathan Brody; Eric R Londin; Isidore Rigoutsos
Journal:  Sci Rep       Date:  2014-08-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.